Week 436 Review - A great week spoiled by Optibiotix and nearly spoiled by a Jubilee Metals placing

An interesting week which saw the nearest thing to a Santa Rally on good inflation news. Unfortunately there's still no sign of an update from OPTI:Optibiotix so the share price dropped 1p. Normally that would have put me deep in the red, but a 21% increase in JLP:Jubilee Metals despite announcing a discounted placing countered the drop and I ended up pretty flat with the deficit between cost and value improving by £165 to £94,653 despite me taking some profits, and overall portfolio value increasing to £110,107.

KIBO:Kibo Energy was the worst performer dropping 13%, but it's 13% of nothing so no worries.

IES:Invinity Energy dropped 7% which is disappointing as they looked like they were on the way back up. At 27p to buy on the market, I decided to let my 50p warrants expire this week.

One of my holdings in JLP:Jubilee Metals dropped 6%. This was a purchase just after the announcement of a new joint venture that should be a game changer for the company, so I bought a load at 6.7p. After assuring shareholders in the past that there would be no more dilution I figured this was a bargain. Two days later they announced a placing at 5.5p. I can understand their reasoning for the placing, but I find it unforgivable that they didn't announce the placing at the same time as the new joint venture. On Friday morning the share price dropped close to 5.5p and I was spitting feathers. It did recover in the afternoon but I was still 6% down in one day. Hopefully this won't matter next week, but I feel let down by what seems like a dirty trick for those in the know to sell into the rise after the joint venture news knowing they could buy back cheaper on Friday morning. "Legally crooked" is the phrase used in a book I'm currently reading.

Onto the good news. CAML:Cental Asia Metals went up by 6% and put one of my holdings into profit. The rest are still down, but if metal prices don't drop then hopefully there can be a sustained rise. With a P/E ratio of just 9.5, these have plenty of room for improvement.

GAW:Games Workshop recovered from last week's big drop and went up by 7% putting my original holding 1% into profit, and my new holding 3% into profit. Happy days.

ASHM:Ashmore Group have been flying, and went up another 8% this week. They are still 24% down, but it means I can change their colour to orange from orange-red.

FXPO:Ferrexpo also went up 8%. I don't think they will re-rate until the war in Ukraine is over, and they are still 84% down, but things could be a lot worse and we can just keep hoping they remain safe.

SAE:Simec Atlantis Energy have been quite volatile lately. They went up 10% this week, but I don't hold out much hope of them ever recovering, and in my mind have written them off, but not yet on my balance sheet.

Share of the Week goes to my original holding in JLP:Jubilee Metals which went up 21% after the announcement of the joint venture. The potential income from this alone dwarfs anything we already produce, and this is just a start. There are piles of slag all over the world, and we now have a capital-rich partner to help secure it. I have 247,451 shares, which is more than I have in OPTI:Optibiotix, although they didn't cost as much. They did cost £21,259 though, so it's by far my biggest holding other than OPTI. Given I've already made £18,849 profit from my previous holdings in JLP, they have been my most successful investment. I hope the curse that tends to fall on most companies I buy doesn't fall on these!

Here's the ISA and shares portfolio after week 20 of year 9.

			Weekly Change
Cash	£140.10		-£65.82
Portfolio cost	£99,175.93		+£93.59
Portfolio sell value (bid price-commission)	£51,182.37	(-48.4%)	+£348.06
Potential profits	£2,009.19		-£126.60
Yr 9 Dividends	£191.08		+£0
Yr 9 Interest	£2.46		+£0
Yr 9 Profit from sales	£31.44		+£31.44
Yr 9 proj avg monthly profit	£41.24	(0.7%)	+£4.17
Total Dividends	£12,102.51		+£0
Total Interest	£4.39		+£0
Total Profit from sales	£17,329.97		+£31.44
Average monthly cash profit	£288.46	(4.9%)	-£0.39
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	41%		+0%

I wanted to bed my PAGE:Page Group shares in my ISA but tried to be clever and sold them rather than using the bed & ISA process. Unfortunately I didn't know that AJ Bell won't allow you to transfer cash from your dealing account to your ISA until a day after the settlement date - which is next week! Meanwhile PAGE:Page Group were going up in value meaning I wouldn't be able to get as many back. I decided to buy JLP:Jubilee Metals instead, and it was these shares that dropped by 6% after the placing news. I bought 16,072 at 6.72p costing £1,089.99.

I'm left with a bit of a dilemma, as I now have shares in my AJ Bell dealing account that cost £6,154 but I only have £6,200 of my ISA allowance left for this tax year. I do want to bed them into my ISA, but can't do all of them unless I take a loss or risk trying to bed more than my allowance. I think I'll play it safe and maybe bed my cheaper purchases if they get into profit.

Potential profits dropped because of the drop in OPTI:Optibiotix, and none of my JLP:Jubilee Metals shares are in profit in this account despite the 21% rise.

Heading very slowly in the right direction

Running parallel to the trend line but still below it.

The SIPP looks like this after week 420 overall and week 4 of year 9.

			Weekly Change
Cash	£642.80		+£85.09
Portfolio cost	£102,726.30		+£949.79
Portfolio sell value (bid price - commission)	£56,819.55	(-44.7%)	-£270.15
Potential profits	£1,613.39		-£293.53
Yr 9 Dividends	£70.36		+£56.37
Yr 9 Interest	£0		+£0
Yr 9 Profit from sales	£2,662.56		+£663.11
Yr 9 proj avg monthly profit	£2,941.01	(51.6%)	+£56.77
Total Dividends	£14,705.24		+£56.37
Total Interest	£5.93		+£0
Total Profit from sales	£13,498.46		+£663.11
Average monthly cash profit	£278.92	(4.9%)	+£6.76
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	40%		+1%

A busy week! I got a £56 dividend from PAF:Pan African Resources, but unfortunately my holding has dropped in value by £136 as there seems to have been a sell-off after the dividend. I sold another bunch of OPTI:Optibiotix shares, off-loading 4,000 at 25.675p making £632.69 (160.4%) profit after buying them at 9.56p. I used the proceeds to buy 18,198 shares in JLP:Jubilee Metals at 5.55p on the morning of the announcement of the joint venture costing £1,021.94. These are already up 11% and making £112 potential profit.

I also sold ANTO:Antofagasta as they are no longer in my top 30 magic formula shares. I sold them for 1565.1693p making £30.43 (3.6%) profit. I invested in the company I mentioned last week, buying 198 shares in IPX:Impax Asset Management at 503.0055p costing £1,005.90. These are 2% up and making £23 potential profit in their first week.

I also had my monthly investment in AJB:AJ Bell and the curse struck again. I bought 80 shares at 309.067p after they soared last week on brilliant results, the day before news broke that they were going to have to pay more interest on cash to their customers, at which point the share price tanked. I couldn't believe it! Fortunately common sense prevailed, and the price crept up during the week. Although it's just below what I bought them for, my average is 289p so I'm up 3% on my overall holding.

Long term performance improved by £6 a month so my recent OPTI:Optibiotix sales are helping drag this back to something vaguely respectable. What's less respectable is the portfolio being 44% down on cost price.

My strategy with the SIPP is to move to dividend playing shares, so the JLP:Jubilee Metals holdings will be sold and moved to magic formula shares if they get into decent profit. I'll probably sell some more OPTI:Optibiotix too as I need to reduce the risk of my overweight position given the serial disappointment they are serving up. I may change my mind if we ever get good news on Sweetbiotix, but my faith is being severely tested.

Although moving up, it's at the same pace as the cost so not a material gain.

This demonstrates more accurately that we're worse off than last week, but that does happen when I cash in profits.

The trading account looks like this after week 386 overall and week 22 of year 8.

			Weekly Change
Cash	£141.20		+£0
Portfolio cost	£1,935.11		+£0
Portfolio sell value (bid price - commission)	£1,181.78	(-38.9%)	+£87.21
Potential profits	£0		+£0
Year 8 Dividends	£8.56		+£0
Year 8 Interest	£0		+£0
Year 8 Profit	£283.99		+£0
Yr 8 proj avg monthly profit	£57.62	(+35.7%)	-£2.75
Dividends	£68.66		+£0
Interest	£0.03		+£0
Profit from sales	-£646.70		+£0
Average monthly cash profit	-£6.49	(-4.0%)	+£0.02
(Sold stocks profit + Dividends - Fees / Months)

A great week for JLP:Jubilee Metals was dampened by a drop in SBTX:SkinBioTherapeutix, with my new holding already 27% down in just a few weeks. The curse of the trading account! JLP is still 52% down so I won't be selling them any time soon. BARC:Barclays went up 2% but still have a 12% deficit to make up before breaking even.

Nice!

Pretty much halved the gap to the trend line which is encouraging.

One week until the Christmas break. I think there's a good chance JLP:Jubilee Metals will advance a little this week as they are getting a lot of media attention, and people will realise the placing will accelerate profits significantly. It's too late for OPTI:Optibiotix to give an update so that could very well continue to slide and spoil the fun at the end of the year.

At least after such an action-packed week I'll be up for a bit of a rest so will be relieved if I don't need to buy or sell anything.